Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : NA
Nov 19,2024
Price(EOD): ₹ 55.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 158.46 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on Nov 20,2019 (price: ₹ 17.95)

₹ 1 L

₹ 3.10 L

1W : -9.7% 1M : -14.7% 1Y : 13.2%
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS -9.7% -14.7% 13.2%
SUN PHARMACEUTICAL INDUSTRIES -1.4% -7.1% 48%
CIPLA -3.5% -5.2% 18%
DR REDDYS LABORATORIES -3.9% -10.1% 10.1%
ZYDUS LIFESCIENCES -0.3% -7.3% 52.2%
DIVIS LABORATORIES 1.5% -2.1% 63%
MANKIND PHARMA -2.3% -3% 39.6%
TORRENT PHARMACEUTICALS -1.8% -10.2% 51.3%
LUPIN -2.4% -6.4% 73.9%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Nov 19,2024 ]

Ratio Standalone
P/E
P/B
P/S
26.02
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 6.08 Cr
[Latest Qtr - Jun2024 - Standalone Results ]

1.21
P/B Calculated based on Book Value of Rs 130.31 Cr
[Latest Year - Mar2024 - Standalone Results ]

0.34
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2024 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 10% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
651%
178%
113%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS



AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.24
0.33
0.13
0.23
-
-
-
-
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-39.67%
181.86%
-38%
-42.45%
149.06%
-12.02%
83.45%
70.76%
QtrlyTrend
0
Latest Qtr: Jun2024
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on Nov 19,2024, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Nov 19,2024, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on Nov 19,2024, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 19.97 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 7.40
Fair Value [Median EV / Sales Model] : Rs. 19.97
Fair Value [Median Price / Sales Model] : Rs. 26.14
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 19.97

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Nov 19,2024, AAREY DRUGS & PHARMACEUTICALS is trading at a Premium of 178% based on the estimates of Median Intrinsic Value!